Titre : GMP cyclique

GMP cyclique : Questions médicales fréquentes

Termes MeSH sélectionnés :

Attention Deficit Disorder with Hyperactivity
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "GMP cyclique : Questions médicales les plus fréquentes", "headline": "GMP cyclique : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les GMP cyclique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-08", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "GMP cyclique" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Nucléotides guanyliques", "url": "https://questionsmedicales.fr/mesh/D006150", "about": { "@type": "MedicalCondition", "name": "Nucléotides guanyliques", "code": { "@type": "MedicalCode", "code": "D006150", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.426" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dibutyryl GMP cyclique", "alternateName": "Dibutyryl Cyclic GMP", "url": "https://questionsmedicales.fr/mesh/D003995", "about": { "@type": "MedicalCondition", "name": "Dibutyryl GMP cyclique", "code": { "@type": "MedicalCode", "code": "D003995", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D13.695.827.426.160.325" } } } ], "about": { "@type": "MedicalCondition", "name": "GMP cyclique", "alternateName": "Cyclic GMP", "code": { "@type": "MedicalCode", "code": "D006152", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Ute Römling", "url": "https://questionsmedicales.fr/author/Ute%20R%C3%B6mling", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Fengyang Li", "url": "https://questionsmedicales.fr/author/Fengyang%20Li", "affiliation": { "@type": "Organization", "name": "" } }, { "@type": "Person", "name": "Zhijian J Chen", "url": "https://questionsmedicales.fr/author/Zhijian%20J%20Chen", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology , Howard Hughes Medical Institute , Department of Immunology , and Animal Resource Center , University of Texas Southwestern Medical Center , Dallas 75390-9148 , Texas , United States." } }, { "@type": "Person", "name": "Roshni R Kharadi", "url": "https://questionsmedicales.fr/author/Roshni%20R%20Kharadi", "affiliation": { "@type": "Organization", "name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, MI, United States." } }, { "@type": "Person", "name": "George W Sundin", "url": "https://questionsmedicales.fr/author/George%20W%20Sundin", "affiliation": { "@type": "Organization", "name": "Department of Plant, Soil and Microbial Sciences, Michigan State University, East Lansing, MI, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "iPro2L-DG: Hybrid network based on improved densenet and global attention mechanism for identifying promoter sequences.", "datePublished": "2024-03-06", "url": "https://questionsmedicales.fr/article/38510021", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.heliyon.2024.e27364" } }, { "@type": "ScholarlyArticle", "name": "Less common phenotypes of myelin oligodendrocyte glycoprotein antibody-related diseases in children deserve more attention.", "datePublished": "2024-03-04", "url": "https://questionsmedicales.fr/article/38438553", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41390-024-03058-x" } }, { "@type": "ScholarlyArticle", "name": "Integrating hybrid transfer learning with attention-enhanced deep learning models to improve breast cancer diagnosis.", "datePublished": "2024-02-28", "url": "https://questionsmedicales.fr/article/38435578", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj-cs.1850" } }, { "@type": "ScholarlyArticle", "name": "An improved V-Net lung nodule segmentation model based on pixel threshold separation and attention mechanism.", "datePublished": "2024-02-27", "url": "https://questionsmedicales.fr/article/38413699", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-55178-3" } }, { "@type": "ScholarlyArticle", "name": "No effects of the theta-frequency transcranial electrical stimulation for recall, attention control, and relation integration in working memory.", "datePublished": "2024-02-19", "url": "https://questionsmedicales.fr/article/38439936", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fnhum.2024.1354671" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides nucléiques, nucléotides et nucléosides", "item": "https://questionsmedicales.fr/mesh/D009706" }, { "@type": "ListItem", "position": 3, "name": "Nucléotides", "item": "https://questionsmedicales.fr/mesh/D009711" }, { "@type": "ListItem", "position": 4, "name": "Ribonucléotides", "item": "https://questionsmedicales.fr/mesh/D012265" }, { "@type": "ListItem", "position": 5, "name": "Nucléotides guanyliques", "item": "https://questionsmedicales.fr/mesh/D006150" }, { "@type": "ListItem", "position": 6, "name": "GMP cyclique", "item": "https://questionsmedicales.fr/mesh/D006152" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : GMP cyclique - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur GMP cyclique", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur GMP cyclique", "description": "Comment mesurer le GMP cyclique dans le corps ?\nQuels tests diagnostiques sont utilisés pour le GMPc ?\nLe GMPc est-il impliqué dans des maladies spécifiques ?\nQuels biomarqueurs sont liés au GMPc ?\nComment le GMPc est-il lié à la fonction cardiaque ?", "url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur GMP cyclique", "description": "Quels symptômes sont associés à des niveaux bas de GMPc ?\nDes niveaux élevés de GMPc provoquent-ils des symptômes ?\nLe GMPc affecte-t-il la pression artérielle ?\nQuels symptômes neurologiques sont liés au GMPc ?\nLe GMPc influence-t-il la fonction rénale ?", "url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur GMP cyclique", "description": "Comment maintenir des niveaux sains de GMPc ?\nLe stress affecte-t-il le GMPc ?\nY a-t-il des habitudes à éviter pour le GMPc ?\nL'exercice physique influence-t-il le GMPc ?\nLes suppléments peuvent-ils affecter le GMPc ?", "url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur GMP cyclique", "description": "Quels médicaments augmentent le GMPc ?\nComment le GMPc est-il ciblé dans le traitement des maladies ?\nLe GMPc a-t-il un rôle dans la thérapie génique ?\nQuels effets secondaires sont liés aux traitements du GMPc ?\nLe GMPc est-il impliqué dans des traitements expérimentaux ?", "url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur GMP cyclique", "description": "Quelles complications sont liées à des niveaux anormaux de GMPc ?\nLe GMPc est-il impliqué dans des maladies chroniques ?\nDes niveaux élevés de GMPc peuvent-ils causer des problèmes ?\nLe GMPc est-il lié à des troubles métaboliques ?\nComment le GMPc affecte-t-il la santé mentale ?", "url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur GMP cyclique", "description": "Quels facteurs augmentent le risque d'anomalies de GMPc ?\nL'alimentation influence-t-elle le GMPc ?\nLe vieillissement affecte-t-il le GMPc ?\nLe manque d'exercice influence-t-il le GMPc ?\nLes maladies héréditaires affectent-elles le GMPc ?", "url": "https://questionsmedicales.fr/mesh/D006152?mesh_terms=Attention+Deficit+Disorder+with+Hyperactivity&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment mesurer le GMP cyclique dans le corps ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le GMPc peut être mesuré par des tests biochimiques dans des échantillons de sang ou de tissus." } }, { "@type": "Question", "name": "Quels tests diagnostiques sont utilisés pour le GMPc ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests d'immunoessai et des dosages enzymatiques sont couramment utilisés." } }, { "@type": "Question", "name": "Le GMPc est-il impliqué dans des maladies spécifiques ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux anormaux de GMPc sont associés à des maladies cardiovasculaires et neurologiques." } }, { "@type": "Question", "name": "Quels biomarqueurs sont liés au GMPc ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Le GMPc est souvent mesuré en relation avec d'autres biomarqueurs comme le NO et les prostaglandines." } }, { "@type": "Question", "name": "Comment le GMPc est-il lié à la fonction cardiaque ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Le GMPc régule la relaxation des muscles cardiaques, influençant la fonction cardiaque globale." } }, { "@type": "Question", "name": "Quels symptômes sont associés à des niveaux bas de GMPc ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux bas peuvent entraîner des problèmes de vasodilatation et des troubles circulatoires." } }, { "@type": "Question", "name": "Des niveaux élevés de GMPc provoquent-ils des symptômes ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés peuvent causer des maux de tête et des troubles de la vision." } }, { "@type": "Question", "name": "Le GMPc affecte-t-il la pression artérielle ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le GMPc joue un rôle dans la régulation de la pression artérielle par la vasodilatation." } }, { "@type": "Question", "name": "Quels symptômes neurologiques sont liés au GMPc ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des anomalies de GMPc peuvent être associées à des troubles neurologiques comme l'anxiété." } }, { "@type": "Question", "name": "Le GMPc influence-t-il la fonction rénale ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le GMPc est impliqué dans la régulation de la fonction rénale et de la filtration glomérulaire." } }, { "@type": "Question", "name": "Comment maintenir des niveaux sains de GMPc ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et l'hydratation peuvent aider à maintenir des niveaux sains." } }, { "@type": "Question", "name": "Le stress affecte-t-il le GMPc ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut réduire les niveaux de GMPc, affectant la santé cardiovasculaire." } }, { "@type": "Question", "name": "Y a-t-il des habitudes à éviter pour le GMPc ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter le tabagisme et une consommation excessive d'alcool peut aider à maintenir des niveaux de GMPc." } }, { "@type": "Question", "name": "L'exercice physique influence-t-il le GMPc ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut augmenter les niveaux de GMPc et améliorer la santé cardiovasculaire." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils affecter le GMPc ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certains suppléments, comme les acides gras oméga-3, peuvent influencer positivement les niveaux de GMPc." } }, { "@type": "Question", "name": "Quels médicaments augmentent le GMPc ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les inhibiteurs de la phosphodiestérase, comme le sildénafil, augmentent les niveaux de GMPc." } }, { "@type": "Question", "name": "Comment le GMPc est-il ciblé dans le traitement des maladies ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le GMPc est ciblé pour traiter des maladies cardiovasculaires et pulmonaires par des vasodilatateurs." } }, { "@type": "Question", "name": "Le GMPc a-t-il un rôle dans la thérapie génique ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des approches de thérapie génique visent à moduler les niveaux de GMPc pour traiter certaines maladies." } }, { "@type": "Question", "name": "Quels effets secondaires sont liés aux traitements du GMPc ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure des maux de tête, des rougeurs et des troubles digestifs." } }, { "@type": "Question", "name": "Le GMPc est-il impliqué dans des traitements expérimentaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des recherches explorent l'utilisation de GMPc dans des traitements pour des cancers et des maladies neurodégénératives." } }, { "@type": "Question", "name": "Quelles complications sont liées à des niveaux anormaux de GMPc ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des niveaux anormaux peuvent entraîner des complications cardiovasculaires et neurologiques graves." } }, { "@type": "Question", "name": "Le GMPc est-il impliqué dans des maladies chroniques ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déséquilibres de GMPc sont associés à des maladies chroniques comme l'hypertension." } }, { "@type": "Question", "name": "Des niveaux élevés de GMPc peuvent-ils causer des problèmes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des niveaux élevés peuvent être liés à des troubles de la vision et des migraines." } }, { "@type": "Question", "name": "Le GMPc est-il lié à des troubles métaboliques ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des anomalies de GMPc peuvent contribuer à des troubles métaboliques comme le diabète." } }, { "@type": "Question", "name": "Comment le GMPc affecte-t-il la santé mentale ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres de GMPc sont associés à des troubles de l'humeur et à l'anxiété." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'anomalies de GMPc ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme, l'obésité et le stress chronique augmentent le risque d'anomalies de GMPc." } }, { "@type": "Question", "name": "L'alimentation influence-t-elle le GMPc ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en graisses saturées peut nuire aux niveaux de GMPc." } }, { "@type": "Question", "name": "Le vieillissement affecte-t-il le GMPc ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le vieillissement peut entraîner une diminution des niveaux de GMPc, affectant la santé globale." } }, { "@type": "Question", "name": "Le manque d'exercice influence-t-il le GMPc ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire peut réduire les niveaux de GMPc et augmenter les risques cardiovasculaires." } }, { "@type": "Question", "name": "Les maladies héréditaires affectent-elles le GMPc ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Certaines maladies génétiques peuvent perturber la signalisation du GMPc, augmentant les risques de complications." } } ] } ] }

Sources (10000 au total)

Less common phenotypes of myelin oligodendrocyte glycoprotein antibody-related diseases in children deserve more attention.

To facilitate the identification of less common clinical phenotypes of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) in children.... We retrospectively reviewed medical records of 236 patients with MOGAD. The following phenotypes were considered to be typical for MOGAD: ADEM, ON, TM, and NMOSD. Less common onset clinical phenotypes... 16 cases (6.8%) presented as cortical encephalitis, with convulsions, headache, and fever as the main symptoms. 15 cases were misdiagnosed in the early period. 13 cases (5.5%) showed the overlapping s... 40/236 (16.9%) of children with MOGAD had less common phenotypes. Less common clinical phenotypes of pediatric MOGAD are susceptible to misdiagnosis and deserve more attention.... This is the first comprehensive analysis and summary of all less commonl clinical phenotypes of MOGAD in children, while previous studies have only focused on a specific phenotype or case reports. We ...

No effects of the theta-frequency transcranial electrical stimulation for recall, attention control, and relation integration in working memory.

Recent studies have suggested that transcranial alternating current stimulation (tACS), and especially the theta-frequency tACS, can improve human performance on working memory tasks. However, evidenc... In a relatively large sample of young healthy participants (... For each task administered, we observed significant gains in accuracy neither for the frontal tACS session nor for the parietal tACS session, as compared to the sham session. By contrast, the scores o... The results suggest that canonical measures of WM capacity are strongly stable in time and hardly affected by theta-frequency tACS. Either the tACS effects observed in the n-back and change detection ...

Dual statistical models link baseline visual attention measure to risk for significant symptomatic concussion in sports.

Athletic pre-season testing can establish functional baseline for comparison following concussion. Whether impacts of future concussions may be foretold by such testing is little known.... Two sets of models for a significant burden of concussion were generated: a traditional approach using a series of logistic regressions, and a penalized regression approach using elastic net.... 3091 youth and adult athletes were baseline-assessed. 90 subsequently experienced concussion and 35 were still experiencing a significant burden of concussion when tested within two weeks. Both models... Pre-season testing of visual attention may identify athletes who are at risk for significant sports-related concussion....